A detailed history of Quantum Private Wealth, LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Quantum Private Wealth, LLC holds 73,424 shares of EWTX stock, worth $2.17 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
73,424
Previous 66,774 9.96%
Holding current value
$2.17 Million
Previous $1.2 Million 62.98%
% of portfolio
0.69%
Previous 0.44%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$15.88 - $29.5 $105,602 - $196,175
6,650 Added 9.96%
73,424 $1.96 Million
Q2 2024

Jul 17, 2024

BUY
$15.08 - $21.23 $1,508 - $2,123
100 Added 0.15%
66,774 $1.2 Million
Q1 2024

May 07, 2024

BUY
$9.25 - $19.97 $31,958 - $68,996
3,455 Added 5.47%
66,674 $1.22 Million
Q4 2023

Jan 30, 2024

BUY
$5.51 - $12.1 $8,265 - $18,150
1,500 Added 2.43%
63,219 $691,000
Q3 2023

Nov 02, 2023

BUY
$5.73 - $7.69 $2,865 - $3,845
500 Added 0.82%
61,719 $353,000
Q2 2023

Jul 27, 2023

BUY
$5.71 - $10.29 $71,375 - $128,624
12,500 Added 25.66%
61,219 $474,000
Q1 2023

Apr 19, 2023

BUY
$6.66 - $11.33 $76,330 - $129,853
11,461 Added 30.76%
48,719 $324,000
Q4 2022

Jan 20, 2023

BUY
$7.58 - $11.08 $29,941 - $43,766
3,950 Added 11.86%
37,258 $0
Q3 2022

Nov 01, 2022

BUY
$8.08 - $13.58 $84,330 - $141,734
10,437 Added 45.63%
33,308 $327,000
Q2 2022

Aug 17, 2022

BUY
$5.67 - $9.87 $3,566 - $6,208
629 Added 2.83%
22,871 $182,000
Q1 2022

May 27, 2022

BUY
$9.1 - $18.97 $26,299 - $54,823
2,890 Added 14.93%
22,242 $215,000
Q4 2021

May 26, 2022

BUY
$14.41 - $22.41 $278,862 - $433,678
19,352 New
19,352 $295,000

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.87B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Quantum Private Wealth, LLC Portfolio

Follow Quantum Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantum Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantum Private Wealth, LLC with notifications on news.